After a brutal drawdown, Vertex is quietly doing the things long-term investors usually say they want and one fund just ...
The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback